4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-003241
CEO and Chairman sold 285,187 shares at an average $8.45 ($2,410,700)
- CEO and Chairman acquired 285,187 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +186,080 | $6.32 | $1,176,026 | 2,762,781 | D |
| 2025-02-19 | Sale : show line 2 in the form 10b5-1 | −186,080 | $8.46 | $1,574,237 | 2,576,701 | D |
| 2025-02-20 | Exercise or conversion : show line 3 in the form 10b5-1 | +99,107 | $6.32 | $626,356 | 2,675,808 | D |
| 2025-02-20 | Sale : show line 4 in the form 10b5-1 | −99,107 | $8.44 | $836,463 | 2,576,701 | D |
| Open-market sales · 285,187 sh · avg $8.45 · $2,410,700 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-19 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −186,080 | 99,107 | D |
| 2025-02-20 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −99,107 | 0 | D |
Loading xslF345X05/form4.xml…